BR0012058A - Combinação sinérgica: gabapentina e pregabalina - Google Patents

Combinação sinérgica: gabapentina e pregabalina

Info

Publication number
BR0012058A
BR0012058A BR0012058-8A BR0012058A BR0012058A BR 0012058 A BR0012058 A BR 0012058A BR 0012058 A BR0012058 A BR 0012058A BR 0012058 A BR0012058 A BR 0012058A
Authority
BR
Brazil
Prior art keywords
pregabalin
gabapentin
synergistic combination
pregabalina
gabapentina
Prior art date
Application number
BR0012058-8A
Other languages
English (en)
Inventor
Roger N Brummel
Lakhbir Singh
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BR0012058A publication Critical patent/BR0012058A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: "COMBINAçãO SINéRGICA : GABAPENTINA E PREGABALINA". A presente invenção é uma composição farmacêutica sinérgica de gabapentina e pregabalina que compreende um método melhorado para o tratamento de dor.
BR0012058-8A 1999-07-02 2000-06-21 Combinação sinérgica: gabapentina e pregabalina BR0012058A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14221599P 1999-07-02 1999-07-02
PCT/US2000/017039 WO2001001983A1 (en) 1999-07-02 2000-06-21 A synergistic combination: gabapentin and pregabalin

Publications (1)

Publication Number Publication Date
BR0012058A true BR0012058A (pt) 2002-05-14

Family

ID=22499016

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0012058-8A BR0012058A (pt) 1999-07-02 2000-06-21 Combinação sinérgica: gabapentina e pregabalina

Country Status (14)

Country Link
EP (1) EP1196160B1 (pt)
JP (1) JP2003503453A (pt)
AR (1) AR030024A1 (pt)
AT (1) ATE313322T1 (pt)
AU (1) AU5753900A (pt)
BR (1) BR0012058A (pt)
CA (1) CA2373953A1 (pt)
CO (1) CO5210869A1 (pt)
DE (1) DE60024995T2 (pt)
ES (1) ES2255500T3 (pt)
MX (1) MXPA02000170A (pt)
PE (1) PE20010331A1 (pt)
UY (1) UY26230A1 (pt)
WO (1) WO2001001983A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1094757C (zh) 1996-07-24 2002-11-27 沃尼尔·朗伯公司 用于治疗疼痛的异丁基γ－氨基丁酸及其衍生物
JP4428053B2 (ja) * 2002-02-05 2010-03-10 味の素株式会社 ガバペンチン若しくはプレガバリンおよびｎ型カルシウムチャンネル拮抗剤を含有する医薬組成物
US7687080B2 (en) * 2002-11-25 2010-03-30 Taraxos Inc. Treatment of neuropathy
WO2004084880A1 (en) * 2003-03-21 2004-10-07 Dynogen Pharmaceuticals, Inc. METHODS FOR TREATING PAIN USING SMOOTH MUSCLE MODULATORS AND α2δ SUBUNIT CALCIUM CHANNEL MODULATORS
WO2004084881A1 (en) * 2003-03-21 2004-10-07 Dynogen Pharmaceuticals, Inc. METHODS FOR TREATING FUNCTIONAL BOWEL DISORDERS USING α2δ SUBUNIT CALCIUM CHANNEL MODULATORS WITH SMOOTH MUSCLE MODULATORS
PL378583A1 (pl) * 2003-03-21 2006-05-02 Dynogen Pharmaceuticals, Inc. Sposoby leczenia zaburzeń dolnych dróg układu moczowego z zastosowaniem modulatorów mięśni gładkich i modulatorów podjednostki Ó2Ű kanałów wapniowych
JP2005060311A (ja) * 2003-08-13 2005-03-10 Mochida Pharmaceut Co Ltd Ｎ−（ベンゾイル）アミノ酸誘導体を有効成分とするニューロパシー性疼痛治療剤
DE102007019071A1 (de) * 2007-04-23 2008-10-30 Ratiopharm Gmbh Stabilisierte pharmazeutische Zusammensetzung enthaltend Pregabalin
AU2009296457A1 (en) 2008-09-27 2010-04-01 Taraxos Inc. Topical formulations for treatment of neuropathy
WO2010115612A2 (en) * 2009-04-10 2010-10-14 Synthon B.V. Pregabalin compositions
BR122021013836B1 (pt) 2009-12-04 2022-05-24 Sunovion Pharmaceuticals, Inc. Composto e seu uso, composição farmacêutica

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9019198A (en) * 1997-08-19 1999-03-08 Warner-Lambert Company Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotor stimulants
DE19802327A1 (de) * 1998-01-23 1999-07-29 Goedecke Ag Synergistische Arzneimittelzubereitung mit analgetischer Wirkung
US6451857B1 (en) * 1999-03-10 2002-09-17 Warner-Lambert Company Analgesic compositions comprising anti-epileptic compounds and methods of using same

Also Published As

Publication number Publication date
AR030024A1 (es) 2003-08-13
CA2373953A1 (en) 2001-01-11
CO5210869A1 (es) 2002-10-30
MXPA02000170A (es) 2002-07-02
ATE313322T1 (de) 2006-01-15
EP1196160A1 (en) 2002-04-17
EP1196160B1 (en) 2005-12-21
DE60024995D1 (de) 2006-01-26
DE60024995T2 (de) 2006-06-22
ES2255500T3 (es) 2006-07-01
WO2001001983A1 (en) 2001-01-11
UY26230A1 (es) 2001-03-16
PE20010331A1 (es) 2001-03-22
JP2003503453A (ja) 2003-01-28
AU5753900A (en) 2001-01-22

Similar Documents

Publication Publication Date Title
BR0316906A (pt) administração do capsaicinoides
BR9913288A (pt) Composição antioxidante compreendendo acetil l-carnitina e ácido alfa-lipóico
BR0013122A (pt) Ciclobenzaprina para tratamento de distúrbio de ansiedade generalizado e composições de ciclobenzaprina
BR9814327A (pt) Compostos de tiouréia e benzamida, composições e pro-cessos para tratamento ou prevenção de doenças infla-matórias e arteriosclerose
HK1070305A1 (en) Pharmaceutical composition comprising gabapentin or an analogue thereof and an sg(a)-aminoamide and its analgesic use
BR9810403A (pt) Sais da sertralina e formas de dosagem de liberação sustentada da sertralina
ATE461698T1 (de) Gaba-analoga zur verhütung und behandlung gastrointestinaler beschwerden
BR9911440A (pt) Composição para a prevenção e/ou tratamento de osteoporose e alterações devido à sìndrome de menopausa
BR0008323A (pt) Derivado de gabapentina para a prevenção e o tratamento de dor visceral
BR0315597A (pt) Processos de baixa dose para tratamento de distúrbios em que a atividade de tnf(alfa)é prejudicial
BR0115411A (pt) Combinações sinergìsticas compreendendo um inibidor de renina para doenças cardiovasculares
BR9911887A (pt) Método para o tratamento da insÈnia
SI1509232T1 (sl) Kombinacija antagonista nmda in zaviralcev acetilholinesteraze za zdravljenje alzheimerjeve bolezni
BR0012058A (pt) Combinação sinérgica: gabapentina e pregabalina
BR9912179A (pt) Composição neuroprotetora para a prevenção e/ou tratamento de alterações nervosas e do comportamento devido a estados de ansiedade ou depressão
BR9915918A (pt) Combinação de carnitinas e resveratrol para prevenção ou tratamento de distúrbios cerebrais ou de envelhecimento
BR9914940A (pt) Método para aperfeiçoar a farmacocinética de tipranavir
ES2136252T3 (es) Tratamiento de enfermedades causadas por trastornos de la glandula sebacea mediante el uso de inhibidores de acil coa colesterol acil transferasa.
BR9911917A (pt) Composições compreendendo análogos de gaba e cafeìna
BR9814711A (pt) Composições e processos para aumentar a concentração e/ou motilidade de espermatozóides em seres humanos
BR9812660A (pt) Composições e métodos para tratar distúrbios respiratórios
BR9907770A (pt) Mistura sinérgica de produtos naturais e seu uso
BR0313413A (pt) Uso da vacinação beta amilóide juntamente com um inibidor da cox-2 seletivo para o tratamento da doença de alzheimer
BR0212989A (pt) Métodos para tratamento neuroprotetor usando inibidores de inos seletivos
BR9809673A (pt) Derivados de triptolida úteis no tratamento de doenças autoimunes

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements